This prospective pilot study is exploratory in nature and is designed to evaluate the validity of continuous glucose monitor (CGM) use for perioperative glucose surveillance during scheduled Cesarean delivery for nondiabetic patients. Primary objective is characterization of perioperative glucose trends during elective Cesarean delivery in patients without diabetes and exploratory analyses will describe perioperative glucose patterns captured by CGM. Secondary objective is to examine rates of and associations with post-operative complications, including surgical site infections.
Study Type
OBSERVATIONAL
Enrollment
150
Continuous glucose monitor during perioperative Cesarean delivery
Icahn School of Medicine at Mount Sinai
New York, New York, United States
interstitial glucose from CGM device
glucose of interstitial fluid as measured by CGM device on participant's arm
Time frame: from pre-operative appointment through end of postpartum hospital stay, up to ten days
Number of surgical site infection
Diagnosis of surgical site infection as a measure of post-operative complications
Time frame: Post-op through end of postpartum hospital say, up to ten days.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.